Found: 15
Select item for more details and to access through your institution.
Point of Care Liquid Biopsy for Cancer Treatment—Early Experience from a Community Center.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2505, doi. 10.3390/cancers16142505
- By:
- Publication type:
- Article
Feasibility of Point-of-Care Genomic Profiling in the Diagnosis and Treatment of Cancer of Unknown Primary.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 474, doi. 10.1093/oncolo/oyad054
- By:
- Publication type:
- Article
Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive‐Stage Small Cell Lung Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 981, doi. 10.1634/theoncologist.2020-0193
- By:
- Publication type:
- Article
Personalizing health care: feasibility and future implications.
- Published in:
- BMC Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1741-7015-11-179
- By:
- Publication type:
- Article
Personalizing health care: feasibility and future implications.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Multi-disciplinary proactive follow-up algorithm for patients with advanced NSCLC receiving afatinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC.
- Published in:
- Current Oncology, 2023, v. 30, n. 7, p. 6473, doi. 10.3390/curroncol30070476
- By:
- Publication type:
- Article
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer.
- Published in:
- Current Oncology, 2023, v. 30, n. 7, p. 6289, doi. 10.3390/curroncol30070465
- By:
- Publication type:
- Article
Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer.
- Published in:
- Current Oncology, 2022, v. 29, n. 7, p. 4981, doi. 10.3390/curroncol29070396
- By:
- Publication type:
- Article
Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care.
- Published in:
- Current Oncology, 2022, v. 29, n. 3, p. 1326, doi. 10.3390/curroncol29030113
- By:
- Publication type:
- Article
A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre.
- Published in:
- Current Oncology, 2022, v. 29, n. 2, p. 869, doi. 10.3390/curroncol29020074
- By:
- Publication type:
- Article
Safety Related to the Timing of Radiotherapy and Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer: A Single Institutional Experience.
- Published in:
- Current Oncology, 2022, v. 29, n. 1, p. 221, doi. 10.3390/curroncol29010021
- By:
- Publication type:
- Article
The Evolving Role of Immunotherapy in Stage III Non-Small Cell Lung Cancer.
- Published in:
- Current Oncology, 2021, v. 28, n. 6, p. 5408, doi. 10.3390/curroncol28060451
- By:
- Publication type:
- Article
Canadian Consensus Recommendations on the Management of MET-Altered NSCLC.
- Published in:
- Current Oncology, 2021, v. 28, n. 6, p. 4552, doi. 10.3390/curroncol28060386
- By:
- Publication type:
- Article
Intracranial Metastatic Disease: Present Challenges, Future Opportunities.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.855182
- By:
- Publication type:
- Article